These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22309460)

  • 21. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons.
    Knudsen S; Mikkelsen JD; Jennum P
    Neuroreport; 2007 Jan; 18(1):77-9. PubMed ID: 17259865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of cortical thickness in narcolepsy patients with cataplexy.
    Joo EY; Jeon S; Lee M; Kim ST; Yoon U; Koo DL; Lee JM; Hong SB
    Sleep; 2011 Oct; 34(10):1357-64. PubMed ID: 21966067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.
    Fronczek R; Lammers GJ; Balesar R; Unmehopa UA; Swaab DF
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5466-70. PubMed ID: 15985489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A five-year longitudinal study reveals progressive cortical thinning in narcolepsy and faster cortical thinning in relation to early-onset.
    Jeon S; Cho JW; Kim H; Evans AC; Hong SB; Joo EY
    Brain Imaging Behav; 2020 Feb; 14(1):200-212. PubMed ID: 30392082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
    Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facial expression recognition and emotional regulation in narcolepsy with cataplexy.
    Bayard S; Croisier Langenier M; Dauvilliers Y
    J Sleep Res; 2013 Apr; 22(2):170-7. PubMed ID: 23228163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy.
    Dauvilliers Y; Bauer J; Rigau V; Lalloyer N; Labauge P; Carlander B; Liblau R; Peyron C; Lassmann H
    JAMA Neurol; 2013 Oct; 70(10):1305-10. PubMed ID: 23939463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cataplexy in anxious patients: is subclinical narcolepsy underrecognized in anxiety disorders?
    Flosnik DL; Cortese BM; Uhde TW
    J Clin Psychiatry; 2009 Jun; 70(6):810-6. PubMed ID: 19422758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep polygraphic study of children and adolescents with narcolepsy/cataplexy.
    Ferri R; Franceschini C; Zucconi M; Drago V; Manconi M; Vandi S; Poli F; Bruni O; Plazzi G
    Dev Neuropsychol; 2009; 34(5):523-38. PubMed ID: 20183716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal activity in reward brain circuits in human narcolepsy with cataplexy.
    Ponz A; Khatami R; Poryazova R; Werth E; Boesiger P; Bassetti CL; Schwartz S
    Ann Neurol; 2010 Feb; 67(2):190-200. PubMed ID: 20225193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gray matter deficits in young adults with narcolepsy.
    Kim SJ; Lyoo IK; Lee YS; Lee JY; Yoon SJ; Kim JE; Kim JH; Hong SJ; Jeong DU
    Acta Neurol Scand; 2009 Jan; 119(1):61-7. PubMed ID: 18624787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
    Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
    Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy.
    Schwartz S; Ponz A; Poryazova R; Werth E; Boesiger P; Khatami R; Bassetti CL
    Brain; 2008 Feb; 131(Pt 2):514-22. PubMed ID: 18094020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
    Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index-independent metabolic alterations in narcolepsy with cataplexy.
    Poli F; Plazzi G; Di Dalmazi G; Ribichini D; Vicennati V; Pizza F; Mignot E; Montagna P; Pasquali R; Pagotto U
    Sleep; 2009 Nov; 32(11):1491-7. PubMed ID: 19928388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narcolepsy in adolescents.
    Sullivan SS
    Adolesc Med State Art Rev; 2010 Dec; 21(3):542-55, x-xi. PubMed ID: 21302860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.